Literature DB >> 32999657

Ileocecal Burkitt's Lymphoma Presenting as Acute Abdominal Pain.

Mostafa Mosbeh Abdelmaksoud1, Maram Kheder Alshareef1, Alaa Osama Jamjoom1, Mohamed Tarek Hafez1.   

Abstract

Primary gastrointestinal non-Hodgkin's lymphomas are rare tumors which account for about 0.9% of all gastrointestinal tract tumors. They are usually associated with inflammatory bowel disease, previous radiotherapy, and renal transplantation. We report a case of non-Hodgkin's lymphoma involving the ileocecal region in a 46-year-old gentleman who presented with acute abdominal pain that mandated emergency laparotomy.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Gastrointestinal tract tumor; Ileocecal lymphoma; Non-Hodgkin's lymphoma

Year:  2020        PMID: 32999657      PMCID: PMC7506374          DOI: 10.1159/000508998

Source DB:  PubMed          Journal:  Case Rep Oncol        ISSN: 1662-6575


Background

Among all non-Hodgkin's lymphomas, gastrointestinal lymphoma accounts for 5–10% of cases, intestinal lymphoma contributing 15–20% [1]. The majority of these cases arise in the stomach (up to 65% of all gastrointestinal lymphomas), followed by the small bowel (20–30%), with the rest arising in the colon and rectum [1, 2, 3, 4]. B-cell lymphoma of the colon is one of the commonest malignancies of the colon, after carcinoma and carcinoid, though its incidence is rare at less than 0.5% [5]. Owing to its anatomical location, ileocecal lymphomas mostly present with complications, such as intestinal obstruction, which mandates surgical intervention on an emergency basis [6, 7, 8].

Case Presentation

A 46-year-old gentleman presented to our emergency department with a 7-day history of generalized abdominal pain associated with abdominal distension, in addition to multiple attacks of vomiting and loose bowel motion. He denied any history of weight loss, chronic diarrhea, night sweats, or any past medical illness. Upon examination, generalized abdominal distension was noticed, associated with generalized guarding and tenderness all over his abdomen, without any detected impulse at the hernial orifices. Computerized tomography (CT) scanning of the abdomen and pelvis with double oral and IV contrast revealed a segmental mural wall thickening with increased enhancement involving distal ileal loops with a suspected soft tissue mass (Fig. 1), resulting in back dilatation of the jejunal and ileal loops in addition to multiple air-fluid levels within it. Moreover, intraperitoneal fluid collection and multiple mesenteric lymphadenopathy were noticed.
Fig. 1

CT scans of the abdomen and pelvis with double contrast.

On laboratory work-up, the results showed leukocytosis of 26 × 103 and high serum creatinine (1.3 mg/dL) and LDH (>1,995 U/L) levels. As a result, the patient was prepared for an emergent abdominal exploration as a case of small bowel obstruction, after anesthesia assessment and the patient's consent for surgery. Exploratory laparotomy was conducted via mid-line incision with identification of 1.5 L of intraperitoneal pus collection and a mass 5 × 5 cm in size at the terminal ileum with a dirty omentum and multiple hard mesenteric lymph nodes. As a consequence, ileocecal resection was done, followed by primary ileocolic anastomosis. In addition, omentectomy was performed with biopsy of the peritoneum (Fig. 2).
Fig. 2

Excised specimen involving the ileocecal region with its mesentery and part of the peritoneum.

The surgery was finalized after appropriate hemostasis and insertion of two intra-abdominal drains. Postoperatively, the patient was shifted to the intensive care unit for 4 days, and then shifted to a regular room in stable condition. Histopathological assessment of the excised specimens revealed a 9 × 3 cm high-grade B-cell lymphoma (Burkitt's lymphoma) in the ileocecal region with involvement of all mesenteric lymph nodes, the omentum, and the peritoneal biopsy. During the postoperative follow-up, the patient developed right-sided pleural effusion, which was managed by US-guided drainage with the insertion of a pig-tail catheter. Cytological analysis of the drained fluid revealed malignant cells. The patient was transferred to a tertiary care center for further management by adjuvant therapy.

Discussion

According to the latest WHO classification, the B-cell lineage is categorized into five histological subtypes: extranodal marginal lymphoma, follicular lymphoma, mantle cell lymphoma, diffuse large B-cell lymphoma, and Burkitt's lymphoma [9]. Diffuse large B-cell lymphoma is the most frequent histological subtype, which affects the gastrointestinal tract and colon [10]. It consists of rapidly proliferating cells that are more aggressive than those of other B-cell lymphomas. Primary colorectal lymphoma occurs mainly in the older age groups in the 5th to 7th decades of life, with a male:female ratio of 1.5:1 [11]. The manifestation of B-cell lymphoma is varied and depends on the site of the lesion. Most commonly, there are abdominal pain, weight loss, an abdominal mass, and hematochezia, in addition to symptoms of obstruction, such as nausea, vomiting, change in bowel habits [1, 3], obstruction [1, 4], intussusceptions [12, 13], and acute peritonitis due to intestinal perforation [1, 3]. The Lugano classification is the most widely used staging system in clinical practice and is based on the Ann Arbor system modified by Carbone et al. [14]. Stage I describes involvement of only a single nodal group or single extranodal site (IE). Stage II entails involvement of more than one nodal group on the same side of the diaphragm or single extranodal site and adjacent lymph nodes (IIE). At stage III, there is involvement of multiple nodal sites on both sides of the diaphragm, including extranodal sites (IIIE) or the spleen (IIIS). Finally, stage IV includes involvement of the bone marrow or central nervous system, or diffuse visceral involvement [14]. The principal mode of treatment is the combined modality that consists of surgery and chemotherapy [15]. Early-stage tumors should be treated with surgery followed by polychemotherapy, while advanced-stage tumors are treated with multidrug chemotherapy [1, 3]. Surgery is the primary modality for palliation of pain and emergent conditions like obstruction, perforation, and bleeding [16]. In our case, the patient presented with acute abdominal pain, for which an examination was performed, as well as ileocecal resection. Postoperative histopathological assessment of the excised specimens revealed non-Hodgkin's lymphoma in the ileocecal region with metastases to the omentum, peritoneum, and mesenteric lymph nodes, in addition to positive malignant cells in the US-guided aspirated fluid from the right-sided pleural effusion.

Conclusions

Primary ileocecal lymphoma is a rare clinical entity presenting most commonly in older age groups. Its presentation is often nonspecific, which leads to delayed diagnosis, and it may present as acute abdominal pain. The primary treatment modality is surgery followed by chemotherapy. The reported prognosis of colonic lymphoma is poor and recurrences are common; however, with use of R-CHOP, improved survival has been reported.

Statement of Ethics

This article was approved by the Research Committee of the Surgery Department at East Jeddah Hospital, and permission was obtained from the patient to publish all materials related to the case.

Conflict of Interest Statement

The authors declare no conflict of interest.

Funding Sources

This article is self-funded by the authors.

Author Contributions

M.T. Hafez: decision regarding clinical management, idea for the manuscript, and final revision. M.M. Abdelmaksoud: clinical management and writing of the manuscript. M.K. Alshareef: clinical management and data collection. A.O. Jamjoom: clinical management and revision of the manuscript.
  16 in total

Review 1.  Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.

Authors:  N L Harris; E S Jaffe; J Diebold; G Flandrin; H K Muller-Hermelink; J Vardiman
Journal:  Ann Oncol       Date:  2000       Impact factor: 32.976

Review 2.  Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.

Authors:  P L Zinzani; M Magagnoli; G Pagliani; M Bendandi; F Gherlinzoni; E Merla; M Salvucci; S Tura
Journal:  Haematologica       Date:  1997 May-Jun       Impact factor: 9.941

3.  Non-Hodgkin's lymphomas of the colon.

Authors:  Osnat Bairey; Rosa Ruchlemer; Ofer Shpilberg
Journal:  Isr Med Assoc J       Date:  2006-12       Impact factor: 0.892

4.  Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92.

Authors:  P Koch; F del Valle; W E Berdel; N A Willich; B Reers; W Hiddemann; B Grothaus-Pinke; G Reinartz; J Brockmann; A Temmesfeld; R Schmitz; C Rübe; A Probst; G Jaenke; H Bodenstein; A Junker; C Pott; J Schultze; A Heinecke; R Parwaresch; M Tiemann
Journal:  J Clin Oncol       Date:  2001-09-15       Impact factor: 44.544

5.  Gastrointestinal tumors in children and adolescents.

Authors:  Alan P Ladd; Jay L Grosfeld
Journal:  Semin Pediatr Surg       Date:  2006-02       Impact factor: 2.754

6.  Primary colorectal lymphoma.

Authors:  C W Fan; C R Changchien; J Y Wang; J S Chen; K C Hsu; R Tang; J M Chiang
Journal:  Dis Colon Rectum       Date:  2000-09       Impact factor: 4.585

7.  Primary colonic lymphoma.

Authors:  N Doolabh; T Anthony; C Simmang; S Bieligk; E Lee; P Huber; R Hughes; R Turnage
Journal:  J Surg Oncol       Date:  2000-08       Impact factor: 3.454

8.  Tumor spectrum of adult intussusception.

Authors:  Jy-Ming Chiang; Yann-Sheng Lin
Journal:  J Surg Oncol       Date:  2008-11-01       Impact factor: 3.454

9.  Primary ileocecal lymphoma. A study of 22 patients.

Authors:  M J Auger; N C Allan
Journal:  Cancer       Date:  1990-01-15       Impact factor: 6.860

10.  Involvement of the ileocaecal region by non-Hodgkin's lymphoma in adults: clinical features and results of treatment.

Authors:  J W Sweetenham; G M Mead; D H Wright; J J McKendrick; D H Jones; C J Williams; J M Whitehouse
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.